FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

FOCUS ON RESEARCH Volume 355:973-975 September 7, 2006 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Editorial by Drazen, J. M. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Suntharalingam, G. PubMed Citation

The immune system has the remarkable ability to defend against diverse microbial pathogens and yet not to respond to self. T cells are key mediators of the immune response, and their activation is tightly regulated to prevent autoreactivity. The processes of T-cell activation and self-tolerance are therefore potential targets for manipulation by drugs — hence, the recent phase 1 trial of a "superagonistic" monoclonal anti-CD28 antibody that was conducted in Britain on behalf of the German firm TeGenero, with the unexpected and devastating results described by Suntharalingam et al. in this issue of the Journal (pages 1018–1028).

T-cell activation requires . . . [Full Text of this Article]

Source Information

This article was published at www.nejm.org on August 14, 2006.

Dr. Sharpe is a professor of pathology at Harvard Medical School, Boston. Dr. Abbas is a professor and chair of the Department of Pathology at the University of California, San Francisco, San Francisco.

Related Letters:

T-Cell Costimulation
Wise M. P., Gallimore A., Godkin A., Colaco C. A.L.S., Sharpe A., Abbas A.
Extract | Full Text | PDF  
N Engl J Med 2006; 355:2594-2595, Dec 14, 2006. Correspondence

This article has been cited by other articles:

• Albu, D. I., Feng, D., Bhattacharya, D., Jenkins, N. A., Copeland, N. G., Liu, P., Avram, D. (2007). BCL11B is required for positive selection and survival of double-positive thymocytes. J. Exp. Med. 204: 3003-3015 [Abstract] [Full Text]  
• Habicht, A., Dada, S., Jurewicz, M., Fife, B. T., Yagita, H., Azuma, M., Sayegh, M. H., Guleria, I. (2007). A Link between PDL1 and T Regulatory Cells in Fetomaternal Tolerance. J. Immunol. 179: 5211-5219 [Abstract] [Full Text]  
• Mascelli, M. A., Zhou, H., Sweet, R., Getsy, J., Davis, H. M., Graham, M., Abernethy, D. (2007). Molecular, Biologic, and Pharmacokinetic Properties of Monoclonal Antibodies: Impact of These Parameters on Early Clinical Development. J Clin Pharmacol 47: 553-565 [Abstract] [Full Text]  
• Mirenda, V., Jarmin, S. J., David, R., Dyson, J., Scott, D., Gu, Y., Lechler, R. I., Okkenhaug, K., Marelli-Berg, F. M. (2007). Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood 109: 2968-2977 [Abstract] [Full Text]  
• Guleria, I., Sayegh, M. H. (2007). Maternal Acceptance of the Fetus: True Human Tolerance. J. Immunol. 178: 3345-3351 [Abstract] [Full Text]  
• Wise, M. P., Gallimore, A., Godkin, A., Colaco, C. A.L.S., Sharpe, A., Abbas, A. (2006). T-Cell Costimulation. NEJM 355: 2594-2595 [Full Text]  
• Drazen, J. M. (2006). Volunteers at Risk. NEJM 355: 1060-1061 [Full Text]